🏥 Health 9h ago

Anti-VEGF Agent Collects Big Win in Trial of Diabetic Retinopathy

MedPage Today
Medical news for professionals
View Channel →
Anti-VEGF Agent Collects Big Win in Trial of Diabetic Retinopathy
Source ↗ 👁 0 💬 0
(MedPage Today) -- MONTREAL -- Diabetic retinopathy severity and the risk of vision-threatening complications decreased significantly in patients treated with the investigational VEGF inhibitor tarcocimab, a randomized, sham-controlled study...

Comments (0)

Sign in to join the discussion

More Like This

Study Backs NP, PA Prescriptions for Abortion Drugs
MedPageToday.com - medical news for physicians · 6h ago
Anti-VEGF Continuous Delivery Device Preserves Vision, Retinal Anatomy in DME
MedPageToday.com - medical news for physicians · 6h ago
Bill to Block AI Prior Authorization in Medicare Fails in Senate
MedPageToday.com - medical news for physicians · 7h ago
What Was RFK Jr. Accused of This Week?
MedPageToday.com - medical news for physicians · 8h ago
Faster Cognitive Decline Linked to Cumulative Physiologic Stress
MedPageToday.com - medical news for physicians · 8h ago
Oncology Reimbursement Cuts; Cancer-Prone Geckos; Sam Neill's Rare Blood Cancer
MedPageToday.com - medical news for physicians · 8h ago